deguelin has been researched along with Carcinoma, Squamous Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Liang, Q; Liu, H; Liu, W; Yu, X; Zhou, L | 1 |
| Baba, Y; Kato, Y | 1 |
| Baba, Y; Fujii, M; Kato, Y; Maeda, T; Suzuki, A; Takada, S | 1 |
| Bi, ZG; Cheng, L; Gu, B; Ji, C; Lu, CC; Wang, R; Yang, YL | 1 |
4 other study(ies) available for deguelin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma.
Topics: Animals; Apoptosis; Aurora Kinase B; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Rotenone; Xenograft Model Antitumor Assays | 2017 |
Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Therapy, Combination; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase Cell Cycle Checkpoints; Humans; Rotenone; Survival Rate | 2017 |
Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Head and Neck Neoplasms; Humans; Mutant Proteins; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Quinazolines; Rotenone; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tyrphostins | 2017 |
Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Ceramides; Cyclin-Dependent Kinase 4; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Inhibitor of Apoptosis Proteins; Mice; Proto-Oncogene Proteins c-akt; Rotenone; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Survivin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |